Latest Stories
FormFactor (NASDAQ:FORM) Posts Better-Than-Expected Sales In Q4, Stock Soars
Semiconductor testing company FormFactor (NASDAQ:FORM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.6% year on year to $215.2 million. On top of that, next quarter’s revenue guidance ($225 million at the midpoint) was surprisingly good and 10.3% above what analysts were expecting. Its non-GAAP profit of $0.46 per share was 30.6% above analysts’ consensus estimates.
Blue Bird (NASDAQ:BLBD) Exceeds Q4 CY2025 Expectations
School bus company Blue Bird (NASDAQ:BLBD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.1% year on year to $333.1 million. On the other hand, the company’s full-year revenue guidance of $1.5 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1 per share was 24.8% above analysts’ consensus estimates.
e.l.f. Beauty (NYSE:ELF) Reports Strong Q4 CY2025
Cosmetics company e.l.f. Beauty (NYSE:ELF) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 37.8% year on year to $489.5 million. The company’s full-year revenue guidance of $1.61 billion at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP profit of $1.24 per share was 71.4% above analysts’ consensus estimates.
STERIS (NYSE:STE) Beats Q4 CY2025 Sales Expectations
Medical equipment and services company Steris (NYSE:STE). beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 9.2% year on year to $1.50 billion. Its non-GAAP profit of $2.53 per share was in line with analysts’ consensus estimates.
WEX’s (NYSE:WEX) Q4 CY2025: Beats On Revenue
Payment solutions provider WEX (NYSE:WEX) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5.7% year on year to $672.9 million. On the other hand, the company’s full-year revenue guidance of $2.73 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $4.11 per share was 4.7% above analysts’ consensus estimates.
O'Reilly’s (NASDAQ:ORLY) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Auto parts and accessories retailer O’Reilly Automotive (NASDAQ:ORLY) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 7.8% year on year to $4.41 billion. On the other hand, the company’s full-year revenue guidance of $18.85 billion at the midpoint came in 0.6% below analysts’ estimates. Its GAAP profit of $0.71 per share was 1.9% below analysts’ consensus estimates.
Markel Group’s (NYSE:MKL) Q4 CY2025: Strong Sales
Specialty insurance company Markel Group (NYSE:MKL) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.6% year on year to $4.01 billion. Its GAAP profit of $48.75 per share was 21.1% above analysts’ consensus estimates.
Coherent (NYSE:COHR) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Soars
Materials and photonics company Coherent (NYSE:COHR) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 17.5% year on year to $1.69 billion. On top of that, next quarter’s revenue guidance ($1.77 billion at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its non-GAAP profit of $1.29 per share was 7% above analysts’ consensus estimates.
EnerSys (NYSE:ENS) Misses Q4 CY2025 Sales Expectations, Stock Drops
Battery manufacturer EnerSys (NYSE:ENS) missed Wall Street’s revenue expectations in Q4 CY2025 as sales only rose 1.4% year on year to $919.1 million. On the other hand, the company expects next quarter’s revenue to be around $980 million, close to analysts’ estimates. Its non-GAAP profit of $2.77 per share was 1.8% above analysts’ consensus estimates.
MetLife (NYSE:MET) Misses Q4 CY2025 Revenue Estimates
Global insurance giant MetLife (NYSE:MET) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 20.7% year on year to $23.81 billion. Its non-GAAP profit of $2.49 per share was 6.3% above analysts’ consensus estimates.